Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 255

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Androgen receptor coregulators and their involvement in the development and progression of prostate cancer

Chmelar, Renée, Buchanan, Grant, Need, Eleanor F., Tilley, Wayne, Greenberg, Norman M.·2007·International Journal of Cancer

Abstract

The androgen receptor signaling axis plays an essential role in the development, function and homeostasis of male urogenital structures including the prostate gland although the mechanism by which the AR axis contributes to the initiation, progression and metastatic spread of prostate cancer remains somewhat enigmatic. A number of molecular events have been proposed to act at the level of the AR and associated coregulators to influence the natural history of prostate cancer including deregulated expression, somatic mutation, and post‐translational modification. The purpose of this article is to review the evidence for deregulated expression and function of the AR and associated coactivators and corepressors and how such events might contribute to the progression of prostate cancer by controlling the selection and expression of AR targets. © 2006 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.22365

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 250

  1. 10.1210/mend-2-12-1265 · DOI · Paper page
  2. 10.1210/edrv-8-3-338 · DOI · Paper page
  3. 10.1083/jcb.96.6.1662 · DOI · Paper page
  4. 10.1111/j.1432-0436.1983.tb01317.x · doi:10.1111/j.1432-0436.1983.tb01317.x
  5. 10.1210/endo-107-6-1767 · DOI
  6. Cunha GR, 1984, Androgenic effects upon prostatic epithelium are mediated via trophic influences from stroma, Prog Clin Biol Res, 145, 81
  7. 10.1210/endo-128-6-3293 · DOI
  8. 10.1111/j.1432-0436.2005.00047.x · doi:10.1111/j.1432-0436.2005.00047.x
  9. 10.3322/canjclin.55.1.10 · DOI · Paper page
  10. Ruizeveld de Winter JA, 1994, Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer, Am J Pathol, 144, 735
  11. 10.1016/S0022-5347(17)37389-5 · DOI
  12. 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S · DOI
  13. Henshall SM, 2001, Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer, Cancer Res, 61, 423
  14. 10.1002/pros.20154 · DOI
  15. Linja MJ, 2001, Amplification and overexpression of androgen receptor gene in hormone‐refractory prostate cancer, Cancer Res, 61, 3550
  16. Koivisto P, 1997, Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer, Cancer Res, 57, 314
  17. 10.1677/erc.1.00525 · DOI · Paper page
  18. 10.1210/jc.2002-022038 · DOI · Paper page
  19. 10.1200/JCO.2002.10.018 · DOI · Paper page
  20. 10.1002/pros.2990220103 · DOI
  21. 10.1002/(SICI)1097-0045(199603)28:3<162::AID-PROS3>3.0.CO;2-H · DOI
  22. Tilley WD, 1996, Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence, Clin Cancer Res, 2, 277
  23. Taplin ME, 1999, Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist, Cancer Res, 59, 2511
  24. 10.1056/NEJM199505253322101 · DOI · Paper page
  25. Buchanan G, 2001, Collocation of androgen receptor gene mutations in prostate cancer, Clin Cancer Res, 7, 1273
  26. Culig Z, 1994, Androgen receptor activation in prostatic tumor cell lines by insulin‐like growth factor‐I, keratinocyte growth factor, and epidermal growth factor, Cancer Res, 54, 5474
  27. 10.1038/bjc.1998.142 · doi:10.1038/bjc.1998.142
  28. 10.1073/pnas.0408925102 · DOI · Paper page
  29. Shibata H, 1997, Role of co‐activators and co‐repressors in the mechanism of steroid/thyroid receptor action, Recent Prog Horm Res, 52, 141
  30. 10.1016/S0959-437X(99)80021-5 · DOI · Paper page
  31. 10.1210/er.20.3.321 · DOI
  32. 10.1002/1097-0045(20001001)45:2<124::AID-PROS6>3.0.CO;2-7 · doi:10.1002/1097-0045(20001001)45:2<124::aid-pros6>3.0.co;2-7
  33. 10.1093/emboj/19.3.359 · DOI · Paper page
  34. 10.1074/jbc.M306576200 · DOI
  35. 10.1016/S0002-9440(10)64422-7 · DOI
  36. 10.1128/MCB.25.4.1425-1436.2005 · DOI
  37. 10.1128/MCB.25.6.2200-2215.2005 · DOI
  38. 10.1002/(SICI)1521-1878(199810)20:10<860::AID-BIES12>3.0.CO;2-S · doi:10.1002/(sici)1521-1878(199810)20:10<860::aid-bies12>3.0.co;2-s
  39. 10.1074/jbc.M111975200 · DOI
  40. 10.1016/S0021-9258(18)52466-2 · DOI · Paper page
  41. 10.1074/jbc.270.13.7341 · DOI · Paper page
  42. 10.1210/me.9.2.208 · DOI · Paper page
  43. 10.1016/S1096-7192(02)00009-4 · DOI
  44. 10.1093/hmg/ddh181 · DOI
  45. 10.1677/jme.1.01723 · DOI
  46. 10.1093/nar/21.5.1125 · DOI
  47. 10.1042/bj3410515 · DOI
  48. 10.1126/science.2115209 · DOI · Paper page
  49. 10.1038/nsb0595-386 · DOI
  50. 10.1016/0960-0760(93)90338-W · DOI
  51. 10.1074/jbc.275.16.12290 · DOI
  52. 10.1210/me.13.9.1558 · DOI
  53. 10.1074/jbc.275.16.12298 · DOI
  54. 10.1016/S1097-2765(02)00471-9 · DOI · Paper page
  55. 10.1016/S0960-0760(00)00154-0 · DOI
  56. 10.1196/annals.1329.068 · DOI
  57. 10.1074/jbc.M302460200 · DOI · Paper page
  58. 10.1210/me.9.5.605 · DOI · Paper page
  59. 10.1074/jbc.M204131200 · DOI · Paper page
  60. 10.1128/MCB.23.23.8563-8575.2003 · DOI · Paper page
  61. 10.1074/jbc.M004571200 · DOI · Paper page
  62. 10.1073/pnas.081565498 · DOI · Paper page
  63. 10.1038/39645 · DOI · Paper page
  64. 10.1038/375377a0 · DOI · Paper page
  65. 10.1074/jbc.M202809200 · DOI
  66. 10.1016/0303-7207(96)03800-2 · DOI
  67. 10.1016/S0021-9258(18)98349-3 · DOI
  68. Grad JM, 1999, Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen‐mediated up‐regulation of AR messenger RNA, Mol Endocrinol, 13, 1896, 10.1210/mend.13.11.0369 · DOI
  69. 10.1126/stke.2122003re15 · DOI
  70. 10.1158/0008-5472.CAN-06-0411 · DOI
  71. 10.1128/MCB.23.1.104-118.2003 · DOI
  72. 10.1210/er.18.3.306 · DOI
  73. 10.1074/jbc.273.13.7358 · DOI
  74. 10.1074/jbc.273.49.32973 · DOI · Paper page
  75. 10.1016/j.canlet.2004.12.037 · DOI
  76. 10.1126/science.7761850 · DOI · Paper page
  77. 10.1210/me.7.1.4 · DOI · Paper page
  78. 10.1074/jbc.271.23.13468 · DOI
  79. 10.1016/0962-8924(95)80013-7 · DOI
  80. 10.1083/jcb.114.4.609 · DOI · Paper page
  81. 10.1042/bse0400041 · DOI · Paper page
  82. 10.1016/S0968-0004(01)01834-5 · DOI
  83. 10.1016/S0955-0674(97)80066-X · DOI · Paper page
  84. 10.1016/S0092-8674(03)00934-6 · DOI · Paper page
  85. 10.1074/jbc.274.29.20229 · DOI · Paper page
  86. 10.1074/jbc.M403117200 · DOI
  87. 10.1210/mend.16.4.0798 · DOI
  88. 10.1091/mbc.01-10-0513 · DOI
  89. 10.1073/pnas.94.16.8485 · DOI · Paper page
  90. 10.1074/jbc.M205220200 · DOI
  91. 10.1093/emboj/cdg585 · DOI
  92. 10.1074/jbc.273.48.31853 · DOI · Paper page
  93. 10.1128/MCB.21.14.4614-4625.2001 · DOI
  94. 10.1074/jbc.275.13.9308 · DOI
  95. 10.1074/jbc.M108255200 · DOI · Paper page
  96. Park JJ, 2000, Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor, Cancer Res, 60, 5946
  97. 10.1073/pnas.190353897 · DOI
  98. 10.1128/MCB.24.24.10529-10541.2004 · DOI
  99. 10.1073/pnas.1132020100 · DOI
  100. 10.1128/MCB.19.12.8383 · DOI · Paper page
  101. Nishimura K, 2003, Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator, Cancer Res, 63, 4888
  102. 10.1074/jbc.273.47.31528 · DOI
  103. 10.1210/mend.14.1.0408 · DOI
  104. 10.1038/sj.onc.1204489 · DOI
  105. 10.1074/jbc.M000660200 · DOI · Paper page
  106. Janne OA, 2000, Androgen‐receptor‐interacting nuclear proteins, Biochem Soc Trans, 28, 401, 10.1042/bst0280401 · DOI
  107. 10.1074/jbc.274.6.3700 · DOI
  108. 10.1074/jbc.274.12.8316 · DOI · Paper page
  109. 10.1074/jbc.M206061200 · DOI
  110. 10.1074/jbc.274.25.17599 · DOI · Paper page
  111. 10.1073/pnas.93.10.4948 · DOI · Paper page
  112. 10.1074/jbc.274.13.8570 · DOI · Paper page
  113. 10.1074/jbc.274.48.34283 · DOI · Paper page
  114. 10.1074/jbc.M312563200 · DOI
  115. 10.1074/jbc.M106399200 · DOI
  116. 10.1074/jbc.274.32.22373 · DOI
  117. 10.1074/jbc.M408972200 · DOI
  118. 10.1210/endo.141.9.7680 · DOI
  119. 10.1126/science.277.5328.965 · DOI · Paper page
  120. 10.1016/S0092-8674(00)80516-4 · DOI · Paper page
  121. 10.1073/pnas.94.16.8479 · DOI · Paper page
  122. 10.1126/science.270.5240.1354 · DOI · Paper page
  123. 10.1074/jbc.272.44.27629 · DOI · Paper page
  124. 10.1210/mend.12.2.0065 · DOI · Paper page
  125. 10.1016/S0960-0760(00)00027-3 · DOI
  126. 10.1074/jbc.M009916200 · DOI
  127. 10.1038/38304 · DOI · Paper page
  128. 10.1038/383099a0 · DOI · Paper page
  129. 10.1101/gad.12.11.1638 · DOI · Paper page
  130. 10.1210/er.2004-0008 · DOI · Paper page
  131. 10.1016/S0960-0760(03)00222-X · DOI
  132. 10.1126/science.279.5351.703 · DOI · Paper page
  133. 10.1016/S0092-8674(03)00599-3 · DOI
  134. 10.1242/jcs.00734 · DOI
  135. Gregory CW, 2001, A mechanism for androgen receptor‐mediated prostate cancer recurrence after androgen deprivation therapy, Cancer Res, 61, 4315
  136. 10.1158/0008-5472.CAN-04-4076 · DOI
  137. 10.1054/bjoc.2001.2179 · DOI
  138. Debes JD, 2003, p300 in prostate cancer proliferation and progression, Cancer Res, 63, 7638
  139. 10.1002/path.1609 · DOI
  140. 10.1677/erc.1.00775a · DOI
  141. 10.1038/sj.onc.1206121 · DOI
  142. Nagata A, 1991, An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells, New Biol, 3, 959
  143. 10.1038/labinvest.3780254 · DOI
  144. Gasparotto D, 1997, Overexpression of CDC25A and CDC25B in head and neck cancers, Cancer Res, 57, 2366
  145. 10.1126/science.7667636 · DOI · Paper page
  146. 10.1002/ijc.21469 · DOI
  147. 10.1038/sj.onc.1206342 · DOI
  148. 10.1038/nature03452 · DOI · Paper page
  149. 10.1016/S0955-0674(99)80012-X · DOI · Paper page
  150. 10.1002/(SICI)1097-0045(19990615)40:1<14::AID-PROS2>3.0.CO;2-6 · doi:10.1002/(sici)1097-0045(19990615)40:1<14::aid-pros2>3.0.co;2-6
  151. Asch HL, 1996, Widespread loss of gelsolin in breast cancers of humans, mice, and rats, Cancer Res, 56, 4841
  152. Dosaka‐Akita H, 1998, Frequent loss of gelsolin expression in non‐small cell lung cancers of heavy smokers, Cancer Res, 58, 322
  153. Tanaka M, 1995, Gelsolin: a candidate for suppressor of human bladder cancer, Cancer Res, 55, 3228
  154. 10.1126/science.1848726 · DOI · Paper page
  155. 10.1073/pnas.95.15.8532 · DOI
  156. 10.1126/science.278.5336.294 · DOI · Paper page
  157. 10.1074/jbc.M401781200 · DOI
  158. Chang HC, 2005, In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen‐dependent prostate cancer cell line, J Formos Med Assoc, 104, 652
  159. 10.1002/pros.10229 · DOI
  160. 10.1158/1078-0432.CCR-0990-3 · DOI
  161. Kasai M, 2003, The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines, Cancer Res, 63, 4927
  162. 10.1002/pros.10262 · DOI
  163. 10.1210/me.2005-0324 · DOI · Paper page
  164. 10.1042/bj20031456 · DOI
  165. 10.1210/mend.11.6.0004 · doi:10.1210/mend.11.6.0004 · Paper page
  166. 10.1074/jbc.M206374200 · DOI · Paper page
  167. 10.1002/jcb.10757 · DOI
  168. 10.1016/S0090-4295(01)01117-7 · DOI
  169. 10.1073/pnas.0304146101 · DOI · Paper page
  170. 10.1038/35090585 · DOI · Paper page
  171. Magee JA, 2001, Expression profiling reveals hepsin overexpression in prostate cancer, Cancer Res, 61, 5692
  172. LaTulippe E, 2002, Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease, Cancer Res, 62, 4499
  173. 10.1016/S1535-6108(02)00030-2 · DOI · Paper page
  174. 10.1002/mc.10018 · DOI · Paper page
  175. Welsh JB, 2001, Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer, Cancer Res, 61, 5974
  176. 10.1016/j.molcel.2004.09.036 · DOI · Paper page
  177. 10.1074/jbc.274.52.37219 · DOI · Paper page
  178. 10.1210/me.2005-0298 · DOI
  179. 10.1128/MCB.23.6.2135-2150.2003 · DOI
  180. 10.1002/jcb.10653 · DOI · Paper page
  181. 10.1093/nar/26.1.234 · DOI
  182. Buchanan G, 2001, Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function, Mol Endocrinol, 15, 46, 10.1210/mend.15.1.0581 · DOI
  183. 10.1097/01.LAB.0000038924.67707.75 · DOI
  184. 10.1074/jbc.M008207200 · DOI
  185. 10.1023/A:1015531326689 · DOI · Paper page
  186. 10.1038/nsb0196-87 · DOI · Paper page
  187. 10.1038/76287 · DOI · Paper page
  188. 10.1210/me.2001-0281 · DOI
  189. 10.1210/me.2004-0190 · DOI
  190. 10.1016/0960-0760(92)90401-4 · DOI · Paper page
  191. 10.1210/me.2003-0436 · DOI
  192. 10.1002/pros.20191 · DOI
  193. 10.1210/me.2005-0231 · DOI
  194. 10.1210/me.2005-0134 · DOI
  195. 10.1074/jbc.M503850200 · DOI
  196. Truica CI, 2000, β‐Catenin affects androgen receptor transcriptional activity and ligand specificity, Cancer Res, 60, 4709
  197. Voeller HJ, 1998, β‐Catenin mutations in human prostate cancer, Cancer Res, 58, 2520
  198. Cronauer MV, 2005, Effects of WNT/β‐catenin pathway activation on signaling through T‐cell factor and androgen receptor in prostate cancer cell lines, Int J Oncol, 26, 1033
  199. 10.1093/oxfordjournals.jjco.a023188 · DOI
  200. Drobnjak M, 2000, Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone, Clin Cancer Res, 6, 1891

200 of 250 shown

Cited by

See all 255

Metadata

Authors
Chmelar, R., Buchanan, G., Need, E. F., Tilley, W., & Greenberg, N. M.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2006-12-27
Volume
120
Issue
4
Pages
719-733
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2010246016
Cited by
255
References
20
FWCI
13.42
Type
journal article
Language
en
Open access
closed
Funders
  • National Cancer Institute (NMG) (CA73747, CA84296)
  • National Health and Medical Research Council of Australia (WDT) (299048)
  • US Department of Defense (W81XWH-04-1-0017)
  • NHMRC CJ Martin Biomedical Fellowship
  • Florey Adelaide Male Aging Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. https://app.cochat.ai/papers/10.1002/ijc.22365
The paper
Chmelar, R., Buchanan, G., Need, E. F., Tilley, W., & Greenberg, N. M. (2007). Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.22365

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.